Apimeds Pharmaceuticals US, Inc. reports

Company location: Matawan, NJ
Fiscal year end: 31 December

Apimeds Pharmaceuticals US, Inc. has filed 118 SEC EDGAR filings since 29 Jan 2024

Filter by type:
10-K
10-Q
8-K

SEC filing history

Showing 51-75 of 118 matching filings.

Per page

25

Current page

3

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-42545

QUARTERLY REPORT

Filing date: 20 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13D File 005-95043

SCHEDULE 13D filing

Filing date: 19 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 May 2025
Reporting date: 13 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

NT 10-Q File 001-42545

NOTIFICATION OF LATE FILING

Filing date: 15 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 May 2025
Reporting date: 12 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 May 2025
Reporting date: 12 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

PRIMARY DOCUMENT

Filing date: 14 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 12 May 2025
Reporting date: 08 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B4 File 333-282324

PROSPECTUS

Filing date: 09 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .